Thomas A Rasmussen

Summary

Publications

  1. pmc Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, DK 8200 Aarhus N, Denmark
    BMJ 345:e5823. 2012
  2. doi request reprint Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation
    Thomas Aagaard Rasmussen
    Department of Infectious Diseases Aarhus University Hospital Aarhus, Denmark
    Hum Vaccin Immunother 9:993-1001. 2013
  3. pmc Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 7:e32445. 2012
  4. ncbi request reprint Serum procalcitonin in pulmonary tuberculosis
    T A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    Int J Tuberc Lung Dis 15:251-6, i. 2011
  5. pmc Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    BMC Infect Dis 11:267. 2011
  6. pmc Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients
    Anni A Winckelmann
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 8:e62074. 2013

Collaborators

Detail Information

Publications6

  1. pmc Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, DK 8200 Aarhus N, Denmark
    BMJ 345:e5823. 2012
    ..To predict the number of selected outcomes temporally associated but not caused by vaccination, to aid causality assessment of adverse events arising after mass immunisation in a paediatric population...
  2. doi request reprint Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation
    Thomas Aagaard Rasmussen
    Department of Infectious Diseases Aarhus University Hospital Aarhus, Denmark
    Hum Vaccin Immunother 9:993-1001. 2013
    ..We aimed to compare the potential for inducing HIV production and the effect on T-cell activation of potent HDAC inhibitors undergoing clinical investigation...
  3. pmc Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 7:e32445. 2012
    ..Our objective was to compare the bone and renal effects among HIV-infected patients randomized to abacavir or tenofovir-based combination anti-retroviral therapy...
  4. ncbi request reprint Serum procalcitonin in pulmonary tuberculosis
    T A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    Int J Tuberc Lung Dis 15:251-6, i. 2011
    ..To evaluate the level and prognostic value of procalcitonin (PCT) in a West African out-patient cohort with pulmonary tuberculosis (PTB)...
  5. pmc Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy
    Thomas A Rasmussen
    Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
    BMC Infect Dis 11:267. 2011
    ..Our objective was to evaluate and compare the effect of abacavir on levels of biomarkers associated with cardiovascular risk...
  6. pmc Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients
    Anni A Winckelmann
    Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
    PLoS ONE 8:e62074. 2013
    ..Reductions in proviral load correlated with increasing levels of HIV specific CD8+ T cells. Further investigation into the potential effect of TLR9 agonists on HIV latency is warranted...